February 28, 2017 / 10:07 PM / 6 months ago

BRIEF-Jazz Pharmaceuticals Q4 adj earnings per share $2.71

Feb 28 (Reuters) - Jazz Pharmaceuticals Plc:

* Jazz Pharmaceuticals Plc sees 2017 revenues $1,625-$1,700 million

* Jazz Pharmaceuticals Plc sees 2017 total net product sales $1,617-$1,692 million

* Jazz Pharmaceuticals Plc sees 2017 GAAP net income per diluted share $6.55-$7.55

* Jazz Pharmaceuticals Plc sees 2017 NON-GAAP adjusted net income per diluted share $10.70-$11.30

* FY2017 earnings per share view $11.33, revenue view $1.68 billion -- Thomson Reuters I/B/E/S

* Jazz pharmaceuticals announces full year and fourth quarter 2016 financial results

* Q4 adjusted earnings per share $2.71

* Q4 GAAP earnings per share $1.91

* Q4 earnings per share view $2.65 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below